Testing effectiveness (Phase 2)Study completedNCT01765283
What this trial is testing
Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN)
Who this might be right for
Urea Cycle DisordersCrigler Najjar Syndrome
Cellaion SA 20